Science
Powering forward – Genomics England’s COVID-19 response – Drug Target Review
Thorben Seeger reveals how Genomics England’s next-generation genomic research platform will play a key role in the response to COVID-19.
Posted: 11 September 2020 | Nikki Withers (Drug Target Review) | No comments yet
Genomics England has launched a next-generation genomic research platform that will play a key role in the response to COVID-19. It is hoped this research environment will transform how genomic data is made usable for global biopharma and academic scientists, providing worldclass patient data security, while enabling the flexibility required at the cutting edge of science. Nikki Withers spoke to Thorben Seeger, who…
-
Noosa News18 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business16 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General19 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
General21 hours agoFirst home buyers score early access to deposit scheme